Johnson & Johnson (JNJ)

Healthcare
$238.35▲ 0.02 (0.01%)
Real-time prices · US Markets
📅
Next earnings: Jul 15
Bullish
7.1 / 10
High-quality business with 26% return on equity and 22% profit margins.
earnings contracting 53% year-over-year.
Quality
9.3
Health
6.5
Growth
5.1
Valuation
7
Sentiment
6.9
Analyst Target
$252.87
▲ +6.1% from current

Price Chart

Fundamentals

Trailing P/E
27.6×
price-to-earnings
Forward P/E
18.7×
next 12 months est.
Market Cap
$573.8B
market capitalization
Div Yield
2.25%
dividend yield
Profit Margin
21.8%
net profit margin
Gross Margin
68.0%
revenue minus COGS
ROE
26.4%
return on equity
Beta
0.26
vs S&P 500
52-Week Range
$149 — $252
annual min — max

EPS — Estimate vs Actual

Frequently Asked Questions

What do analysts say about Johnson & Johnson right now?
Johnson & Johnson's Q·Score is 7.1/10 (Bullish), reflecting its current fundamentals, analyst data, and valuation metrics. High-quality business with 26% return on equity and 22% profit margins. Key area to monitor: earnings contracting 53% year-over-year. This is an informational data summary only and does not constitute financial advice. Always do your own research before making any investment decision.
What is the analyst price target for JNJ?
The consensus price target for JNJ is $252.87, based on ratings from 23 Wall Street analysts. This is 6.1% above the current price of $238.35. Price targets are forward-looking estimates and not guarantees of future performance.
Is JNJ overvalued or undervalued?
Johnson & Johnson (JNJ) scores favorably on valuation metrics relative to sector peers and analyst targets. Its forward P/E ratio stands at 18.7×. The consensus analyst price target of $252.87 is 6% above the current price.
When does Johnson & Johnson report its next earnings?
Johnson & Johnson's next earnings report is expected on approximately July 15, 2026.
What is Johnson & Johnson's profit margin?
Johnson & Johnson has a net profit margin of 21.8%, which is considered high and reflects strong pricing power. Its gross margin stands at 68.0%, indicating a high-margin business model.
What is JNJ's dividend yield?
Johnson & Johnson currently offers a dividend yield of 2.25%, which is above the typical market average dividend yield. Dividend yields can change based on price movements and company payout decisions.
Is Johnson & Johnson's revenue growing?
Johnson & Johnson is reporting modest revenue growth of 9.9%. However, earnings declined 52.9%, which warrants monitoring.
How much debt does Johnson & Johnson have?
Johnson & Johnson has a debt-to-equity ratio of 0.68×, reflecting a moderate debt level, which is manageable for most profitable companies. Its current ratio is 1.02×, suggesting it should be monitored for near-term liquidity.
Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026